About
Cocrystal Pharma, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 7 2026
COCP: Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Prevention
Apr 2 2026
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
Mar 31 2026
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Mar 9 2026
First Subjects Dosed in Cocrystal Pharma’s Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment
Feb 23 2026
COCP: CDI-988 Data to be Presented at ICAR 2026
Recent Videos

COCP STOCK : POTENTIAL RECOVERY | COCRYSTAL PHARMA STOCK
May 04, 2026

COCP | CoCrystal Pharma FDA Fast Track Catalyst
Apr 06, 2026

COCP | CoCrystal Pharma: April Catalyst Could Explode Stock
Apr 06, 2026

Cocrystal Pharma just filed an 8-K with the SEC disclosing a material event the co... #Shorts
Apr 05, 2026
Translate